Search

Since the publication of this newsletter our founder and honorary president Lynda Cantor MBE has passed away. We are all deeply saddened by this news.

• Look Forward
• Audio
• Written

Our monthly e-Newsletter featuring the latest updates from Retina UK.

• e-Newsletter
• Audio
• Written

The following projects were being funded by Retina UK and have recently come to an end.

Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.

• FAQ
• Written

Genetic testing, usually via a blood sample, is used to try and identify which gene contains the fault that is causing an individual’s sight loss.

Different inherited sight loss conditions present noticeable symptoms at different times.

• Written

Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.

We have created Discover Wellbeing to help people affected by inherited sight loss to develop an awareness of emotional wellbeing and the practical skills to adapt to life’s ups and downs.

We are proud to work with a number of organisations that share our aims and values.

Including a gift to Retina UK in your Will is an incredibly special way to help our vital work continue into the future.